• Go to navigation
  • Go to content
AstraZeneca Clinical Trials

Astrazeneca Worldwide

  • AstraZeneca Websites
AstraZeneca US

Main navigation

  • Home
  • Therapy Areas
    • Oncology/Infection
    • Cardiovascular
    • Gastrointestinal
    • Neuroscience
    • Respiratory/Inflammation
  • Drug Products
    • All Drug Products
  • Diseases & Conditions
    • All Diseases and Conditions
  • Glossary
  • Contact Us
  • Disclosure Commitment

You are here

  • Home
  • Therapy Areas
  • Gastrointestinal
  • Nexium capsules Specific Clinical Experience Investigation for Maintenance Therapy for Repeatedly Recurring/Relapsing Reflux Oesophagitis

Disease
reflux oesophagitis
Drug Name
Nexium
Generic Name
Nexium
Sponsor
AstraZeneca
Drug Status
Approved Medicine
Phase
Non-Interventional Study
Start Date
Jan 18, 1971
Study Name
D961HC00013
Study Id
D961HC00013
ClinicalTrials.gov ID
http://clinicaltrials.gov/ct2/show/NCT01562639?term=NCT01562639&rank=1
Recruiting Status
Not Yet Recruiting
Protocol Status
Not Available
Report Status
Not Available

Page tools

  • Print
  • Bookmark this page

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2013